European drug regulator approves Biocons Malaysia insulin facility

Biopharmaceutical major Biocon said on Thursday said its insulin facility in Malaysia has been approved by the European Medicines Agency. Biocon Sdn Bhd, which operates Asias largest integrated insulin facility, has received the Certificate of Good Manufacturing Practices. The site was inspected in May. "This approval expands Biocons capacities multi-fold with the new large-scale devices facility coming up to speed to serve the growing needs of people with

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.005273 seconds